Paper96136
Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.
Lopaciuk S and 8 others. J Clin Invest, 1978. Cited by 32 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder. Papers, record 96136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/96136
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoimmune Diseases | Major topic |
| Factor XIII | Major topic |
| Hemorrhage | Major topic |
| Adolescent | |
| Antigen-Antibody Reactions | |
| Autoantibodies | |
| Humans | |
| Immunoglobulin Allotypes | |
| Immunoglobulin G | |
| Immunoglobulin kappa-Chains | |
| Male | |
| Middle Aged |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 990,283 | Affinity chromatography of human plasma and platelet factor XIII on organomercurial agarose. | Biochim Biophys Acta | 1976 | https://conductscience.org/library/papers/990283 | PubMed |
| 3 | 1,201,975 | Penicillin allergy and the cephalosporins. | J Antimicrob Chemother | 1975 | https://conductscience.org/library/papers/1201975 | PubMed |
| 4 | 1,237,295 | The reaction of penicillin with proteins. | Biochem J | 1975 | https://conductscience.org/library/papers/1237295 | PubMed |
| 5 | 4,110,351 | Enzymatic coupling of isoniazid to proteins. | Biochemistry | 1972 | https://conductscience.org/library/papers/4110351 | PubMed |
| 6 | 4,133,182 | Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen. | Biochem Biophys Res Commun | 1974 | https://conductscience.org/library/papers/4133182 | PubMed |
| 7 | 4,149,557 | Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures. | J Biol Chem | 1974 | https://conductscience.org/library/papers/4149557 | PubMed |
| 8 | 4,159,100 | Possible induction of antinuclear antibodies by isoniazid. | Lancet | 1966 | https://conductscience.org/library/papers/4159100 | PubMed |
| 9 | 4,405,643 | Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. | J Biol Chem | 1973 | https://conductscience.org/library/papers/4405643 | PubMed |
| 10 | 4,477,004 | The calcium-induced dissociation of human plasma clotting factor XIII. | Biochem J | 1974 | https://conductscience.org/library/papers/4477004 | PubMed |
| 11 | 4,565,370 | Fibrinoligase: the fibrin-stabilizing factor system of blood plasma. | Ann N Y Acad Sci | 1972 | https://conductscience.org/library/papers/4565370 | PubMed |
| 12 | 4,624,720 | Immunochemical characterization of a monoclonal G4,lambda human antibody to factor IX. | Blood | 1972 | https://conductscience.org/library/papers/4624720 | PubMed |
| 13 | 4,632,808 | Immunochemical characterization of a human antibody to factor XIII. | Blood | 1973 | https://conductscience.org/library/papers/4632808 | PubMed |
| 14 | 4,674,979 | A filter paper assay for transamidating enzymes using radioactive amine substrates. | Anal Biochem | 1972 | https://conductscience.org/library/papers/4674979 | PubMed |
| 15 | 4,811,064 | Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. | Biochemistry | 1974 | https://conductscience.org/library/papers/4811064 | PubMed |
| 16 | 4,859,234 | Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. | Biochemistry | 1974 | https://conductscience.org/library/papers/4859234 | PubMed |
| 17 | 4,956,917 | Immunochemical quantitation of antigens by single radial immunodiffusion. | Immunochemistry | 1965 | https://conductscience.org/library/papers/4956917 | PubMed |
| 18 | 4,977,030 | Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation. | J Clin Invest | 1969 | https://conductscience.org/library/papers/4977030 | PubMed |
| 19 | 5,009,823 | Molecular weight analysis of fibrinogen and fibrin chains by an improved sodium dodecyl sulfate gel electrophoresis method. | Biochim Biophys Acta | 1972 | https://conductscience.org/library/papers/5009823 | PubMed |
| 20 | 5,045,959 | Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII). | Br J Haematol | 1972 | https://conductscience.org/library/papers/5045959 | PubMed |
| 21 | 5,096,097 | The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor). | J Biol Chem | 1971 | https://conductscience.org/library/papers/5096097 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,724,593 | Nonhemophiliac musculoskeletal pseudotumor. | J Vasc Surg Cases | 2015 | https://conductscience.org/library/papers/31724593 | PubMed |
| 23,070,535 | Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis. | Int J Hematol | 2012 | https://conductscience.org/library/papers/23070535 | PubMed |
| 23,065,324 | Acquired FXIII inhibitors: a systematic review. | J Thromb Thrombolysis | 2013 | https://conductscience.org/library/papers/23065324 | PubMed |
| 17,252,037 | Case report of an acquired factor XIII inhibitor: diagnosis and management. | Proc (Bayl Univ Med Cent) | 2006 | https://conductscience.org/library/papers/17252037 | PubMed |
| 6,143,256 | Transglutaminases. | Mol Cell Biochem | 1984 | https://conductscience.org/library/papers/6143256 | PubMed |
| 3,422,419 | Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3422419 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F13A1 | 2,162 | PubTator's text mining | https://conductscience.org/library/genes/2162 | NCBI Gene |
| F2 | 2,147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| IGHG3 | 3,502 | PubTator's text mining | https://conductscience.org/library/genes/3502 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/96136
GET https://conductscience.org/api/papers/v1/96136/references?page=2